indication
as of 2026-07-01Mental Disorder
Competitive landscape projected to immunomodulatory treatment by rituximab’s launch window
Competitive set
1
1 approved · 0 pipeline
Projection timeline
actual past → guided future · protection walls overlaid
17 events
2018
2020
2022
2024
2026
2028
2030
2032
2034
2036
2038
2040
2042
today
immunomodulatory treatment by rituximab launch window
guided / estimated ↑
actual ↓
focal / guidedapprovallabel expansiontrial readoutcongressnclustered events (click to expand)guided (dashed = directional)competitor patent cliff
Competitive set
resolved drugs with trials in this indicationdrugCompleted
US-approved 2002 · ABILIFY
Phase 23 trials
Protection2041
Market size
prevalence as a range, not a number